Lung cancer represents a paradigm for carcinogen-induced cancers. Tobacco smoke has over 100 carcinogenic agents and the specific interactions of specific carcinogens with genes that suppress tumors and repair DNA have been identified [1]. Lung cancers show multiple genetic lesions and these can be detected even in histologically normal bronchial mucosa from individuals with a smoking history. These genetic abnormalities provide an array of targets for therapy. The p53 tumor suppressor gene appears to play a central role in lung cancer development and was the initial focus of gene therapy approaches to lung cancer.
CITATION STYLE
Roth, J. A. (2006). Gene therapy for lung cancer. In Tumors of the Chest: Biology, Diagnosis and Management (pp. 431–438). Springer Berlin Heidelberg. https://doi.org/10.1007/3-540-31040-1_36
Mendeley helps you to discover research relevant for your work.